|
Anti-inhibitor Coagulant Complex
|
|
Autoplex T; FEIBA VH Immuno
|
Anti-inhibitor Coagulant Complex Clinical Trials
- Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
Head and Neck Cancer
- GW786034 in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00054093 - Active, not recruiting
Non-small cell lung cancer
- SU011248 in Treating Women With Metastatic Breast Cancer That Did Not Respond to Anthracycline or Taxane Chemotherapy
ClinicalTrials.gov Identifier: NCT00095615 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00068653 - Active, not recruiting
recurrent non-small cell lung cancer
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
Head and Neck Cancer
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00053885 - Active, not recruiting
advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
- AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00243061 - Recruiting
Intraocular Melanoma; Melanoma
- Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- AZD2171 in Treating Patients With Progressive Locally Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00227760 - Active, not recruiting
Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
ClinicalTrials.gov Identifier: NCT00056576 - Active, not recruiting
Epilepsy, Complex Partial
- Study of Proteins Associated with Complex Regional Pain Syndrome
ClinicalTrials.gov Identifier: NCT00033969 - Active, not recruiting
Complex Regional Pain Syndromes; Healthy
- Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- ZD6474 in Treating Patients With Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00066313 - Active, not recruiting
extensive stage small cell lung cancer; limited stage small cell lung cancer
- AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00107237 - Active, not recruiting
adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
- AZD2171 in Treating Patients With Locally Advanced or Metastatic Liver Cancer
ClinicalTrials.gov Identifier: NCT00238394 - Active, not recruiting
Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
- Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
- A Study of the Efficacy and Safety of RWJ-333369 as Add-on Therapy in the Treatment of Partial Onset Seizures.
ClinicalTrials.gov Identifier: NCT00425282 - Active, not recruiting
Epilepsy; Epilepsy, Focal; Complex Partial Seizures; Seizure Disorder; Epilepsy, Complex Partial
- A Study of the Efficacy and Safety of RWJ-333369 as Add-on Therapy in the Treatment of Partial Onset Seizures.
ClinicalTrials.gov Identifier: NCT00433667 - Active, not recruiting
Epilepsy; Complex Partial Seizures; Epilepsy, Complex Partial; Seizure Disorder; Epilepsy, Focal
- PET Imaging of Brain Peripheral Benzodiazepine Receptors in Healthy People and in HIV-Infected People
ClinicalTrials.gov Identifier: NCT00459693 - Recruiting
HIV-Dementia; HIV-Associated Cognitive Motor Complex; AIDS Encephalopathy; AIDS Dementia Complex; AIDS-Related Dementia Complex; HIV Infections
- Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
ClinicalTrials.gov Identifier: NCT00126620 - Recruiting
unspecified adult solid tumor, protocol specific
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00245063 - Recruiting
Recurrent Small Cell Lung Cancer
- Safety Study of an Oral VEGF Receptor Inhibitor When Combined With an m-Tor Inhibitor in Renal Cell Cancer Patients
ClinicalTrials.gov Identifier: NCT00563147 - Active, not recruiting
Renal Cell Carcinoma
- A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
ClinicalTrials.gov Identifier: NCT00576433 - Recruiting
Rheumatoid Arthritis
- A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
ClinicalTrials.gov Identifier: NCT00502840 - Recruiting
Rheumatoid Arthritis
- Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00072475 - Recruiting
Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
- Enzastaurin in Treating Patients With Recurrent Gliomas
ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
adult brain tumor
- Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
Lung Cancer
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
ClinicalTrials.gov Identifier: NCT00030498 - Active, not recruiting
Cancer
- Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy
ClinicalTrials.gov Identifier: NCT00066339 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00072072 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00093652 - Active, not recruiting
Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
- Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062101 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00124605 - Active, not recruiting
unspecified adult solid tumor, protocol specific; refractory plasma cell neoplasm; stage III multiple myeloma; stage II multiple myeloma
- Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00085566 - Active, not recruiting
adult glioblastoma; recurrent prostate cancer; recurrent adult brain tumor; stage IV prostate cancer; adult giant cell glioblastoma; ...
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
intraocular melanoma; Melanoma
- A Study to Evaluate the Use of Memantine In Combination with Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
ClinicalTrials.gov Identifier: NCT00000867 - Completed
AIDS Dementia Complex; HIV Infections
- Sorafenib in Treating Patients with Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
Stage IV Melanoma
- Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
adult soft tissue sarcoma
- Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
ClinicalTrials.gov Identifier: NCT00126555 - Recruiting
squamous cell carcinoma of the skin; recurrent skin cancer
- Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
ClinicalTrials.gov Identifier: NCT00025675 - Active, not recruiting
adult brain tumor
- Zemaira in Subjects With Emphysema Due to API Deficiency
ClinicalTrials.gov Identifier: NCT00261833 - Recruiting
Alpha1-Proteinase Inhibitor Deficiency
- ZD 1839 in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00014170 - Active, not recruiting
adult glioblastoma multiforme
- AEE788 in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00085215 - Recruiting
adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
- LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00052273 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
ClinicalTrials.gov Identifier: NCT00009906 - Active, not recruiting
gastrointestinal stromal tumor
- Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
ClinicalTrials.gov Identifier: NCT00449436 - Recruiting
HIV Infections
- Imatinib Mesylate in Treating Patients With Gliomas
ClinicalTrials.gov Identifier: NCT00039364 - Active, not recruiting
adult brain tumor
- Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00101348 - Recruiting
Gastrointestinal Cancer; Head and Neck Cancer; kidney and urinary cancer; thorax and respiratory cancer
- Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
ClinicalTrials.gov Identifier: NCT00112671 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter
- Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00045591 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- SU011248 or Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098657 - Recruiting
recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
ClinicalTrials.gov Identifier: NCT00227773 - Not yet recruiting
Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
- Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00024089 - Active, not recruiting
Head and Neck Cancer
- Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00098631 - Active, not recruiting
Head and Neck Cancer
- Sorafenib in Treating Patients With Recurrent Diffuse Large B-Cell Non-Hodgkin''s Lymphoma
ClinicalTrials.gov Identifier: NCT00131937 - Active, not recruiting
recurrent adult diffuse large cell lymphoma
- Biological Therapy in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00005853 - Active, not recruiting
Myelodysplastic Syndromes
- Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
ClinicalTrials.gov Identifier: NCT00124657 - Recruiting
adult brain tumor; Childhood Oligodendroglioma; high-grade childhood cerebral astrocytoma; low-grade childhood cerebral astrocytoma; ...
- Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer
ClinicalTrials.gov Identifier: NCT00027690 - Active, not recruiting
recurrent endometrial cancer
- Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
ClinicalTrials.gov Identifier: NCT00096447 - Active, not recruiting
recurrent endometrial cancer
- SU011248 in Treating Patients With Malignant Gastrointestinal Stromal Tumor
ClinicalTrials.gov Identifier: NCT00085618 - Active, not recruiting
gastrointestinal stromal tumor
- Hemophilia Inhibitor Genetics Study (HIGS)
ClinicalTrials.gov Identifier: NCT00166387 - Recruiting
Hemophilia A With Inhibitor
- Lapatinib in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103194 - Active, not recruiting
recurrent prostate cancer
- Predictors of Response to Biventricular Pacing in Heart Failure
ClinicalTrials.gov Identifier: NCT00156390 - Recruiting
Heart Failure, Wide QRS complex
- Sorafenib in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00096434 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Sorafenib in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00107432 - Active, not recruiting
advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
- Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00093626 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
ClinicalTrials.gov Identifier: NCT00025246 - Active, not recruiting
gastrointestinal stromal tumor
- Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery
ClinicalTrials.gov Identifier: NCT00041197 - Active, not recruiting
gastrointestinal stromal tumor
- Sorafenib and Gemcitabine in Treating Patients With Recurrent or Refractory Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00096395 - Active, not recruiting
peritoneal cavity cancer; recurrent ovarian epithelial cancer
- Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
ClinicalTrials.gov Identifier: NCT00074308 - Recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma; unspecified adult solid tumor, protocol specific
- MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas
ClinicalTrials.gov Identifier: NCT00098891 - Active, not recruiting
adult solid tumor; Leukemia; Lymphoma; small intestine cancer
- Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00091078 - Active, not recruiting
gastrointestinal stromal tumor
- Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00039104 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00055770 - Active, not recruiting
Head and Neck Cancer
- ZD 1839 in Treating Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00033579 - Active, not recruiting
recurrent prostate cancer
- Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Gefitinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00096265 - Recruiting
brain metastases; recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
- Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
ClinicalTrials.gov Identifier: NCT00042991 - Active, not recruiting
untreated childhood brain stem glioma
- Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00085059 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse
ClinicalTrials.gov Identifier: NCT00016991 - Active, not recruiting
recurrent adult brain tumor; adult glioblastoma multiforme
- Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
ClinicalTrials.gov Identifier: NCT00062205 - Active, not recruiting
recurrent tumors of the Ewing's family
- Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00068432 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00114244 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00087035 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed
ClinicalTrials.gov Identifier: NCT00049543 - Active, not recruiting
Non-small cell lung cancer
- Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084786 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00107250 - Recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; stage IV colon cancer; ...
- TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previousl
ClinicalTrials.gov Identifier: NCT00513513 - Active, not recruiting
HIV Infections
- ZD6474, Carboplatin, and Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00093392 - Recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00047294 - Active, not recruiting
Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00068497 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- Erlotinib and Tipifarnib in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00085553 - Active, not recruiting
unspecified adult solid tumor, protocol specific
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
